Correlation Between Neurocrine Biosciences and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and HUTCHMED DRC, you can compare the effects of market volatilities on Neurocrine Biosciences and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and HUTCHMED DRC.

Diversification Opportunities for Neurocrine Biosciences and HUTCHMED DRC

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neurocrine and HUTCHMED is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and HUTCHMED DRC

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.41 times more return on investment than HUTCHMED DRC. However, Neurocrine Biosciences is 2.42 times less risky than HUTCHMED DRC. It trades about 0.33 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.1 per unit of risk. If you would invest  11,913  in Neurocrine Biosciences on October 20, 2024 and sell it today you would earn a total of  2,413  from holding Neurocrine Biosciences or generate 20.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  HUTCHMED DRC

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Neurocrine Biosciences and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and HUTCHMED DRC

The main advantage of trading using opposite Neurocrine Biosciences and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind Neurocrine Biosciences and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data